Scientists from the UK introduced the world's first vaccine against malaria. Its effectiveness is confirmed by the European medicines Agency. The drug is expected to greatly reduce the incidence of malaria in epidemic countries.
In the first stage, the vaccine will get all children in regions with a high risk of Contracting malaria. At first I vaccinated children on the African continent. Developer GlaxoSmithKline has no plans to profit from the sale of their drug. The main goal is the reduction of morbidity and improvement of quality of life in Africa.
Every year malaria kills more than half a million people worldwide, most of them are small children. The problem of malaria in developed countries is on a par with AIDS and parasitic diseases.